Lead Product(s) : Arbutin
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Canadian Glycomics Network
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety Evaluation of β-arbutin in Healthy Human Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
March 11, 2019
Lead Product(s) : Arbutin
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Canadian Glycomics Network
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
